120 related articles for article (PubMed ID: 35654004)
1. Cohesin RAD21 Gene Promoter Methylation Correlated with Better Prognosis in Breast Cancer Patients.
Cui R; Chen P; Wang Y; Lu R; Ji M; Hou P; Qu Y
Cytogenet Genome Res; 2022; 162(3):109-118. PubMed ID: 35654004
[TBL] [Abstract][Full Text] [Related]
2. Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.
Yan M; Xu H; Waddell N; Shield-Artin K; Haviv I; ; McKay MJ; Fox SB
Breast Cancer Res; 2012 Apr; 14(2):R69. PubMed ID: 22537934
[TBL] [Abstract][Full Text] [Related]
3. Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers.
Xu H; Yan M; Patra J; Natrajan R; Yan Y; Swagemakers S; Tomaszewski JM; Verschoor S; Millar EK; van der Spek P; Reis-Filho JS; Ramsay RG; O'Toole SA; McNeil CM; Sutherland RL; McKay MJ; Fox SB
Breast Cancer Res; 2011 Jan; 13(1):R9. PubMed ID: 21255398
[TBL] [Abstract][Full Text] [Related]
4. Cohesin subunit RAD21: From biology to disease.
Cheng H; Zhang N; Pati D
Gene; 2020 Oct; 758():144966. PubMed ID: 32687945
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.
Minatani N; Waraya M; Yamashita K; Kikuchi M; Ushiku H; Kojo K; Ema A; Nishimiya H; Kosaka Y; Katoh H; Sengoku N; Tanino H; Sidransky D; Watanabe M
PLoS One; 2016; 11(1):e0144862. PubMed ID: 26785325
[TBL] [Abstract][Full Text] [Related]
6. Extent of breast cancer type 1 promoter methylation correlates with clinicopathological features in breast cancers.
Sun MY; Chang XZ; Xu GY; Dong Y; Zhou ZJ; Liu T; Wang CQ; Li YS
J Cancer Res Ther; 2018 Jun; 14(Supplement):S354-S361. PubMed ID: 29970689
[TBL] [Abstract][Full Text] [Related]
7. Cohesin is required for activation of MYC by estradiol.
McEwan MV; Eccles MR; Horsfield JA
PLoS One; 2012; 7(11):e49160. PubMed ID: 23145106
[TBL] [Abstract][Full Text] [Related]
8. Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast Cancer.
Moghazy TF; ElAttar HA; Eldeeb MK; Rashad RM; Farouk AM; Farag AM
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2523-2530. PubMed ID: 31450928
[TBL] [Abstract][Full Text] [Related]
9. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
[TBL] [Abstract][Full Text] [Related]
10. Cohesin RAD21 Gene Promoter Methylation in Patients with Chronic Lymphocytic Leukemia.
Ioannidou A; Zachaki S; Karakosta M; Daraki A; Roussou P; Manola KN
Cytogenet Genome Res; 2018; 154(3):126-131. PubMed ID: 29587287
[TBL] [Abstract][Full Text] [Related]
11. Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer.
Gupta V; Agarwal P; Deshpande P
Ann Diagn Pathol; 2021 Jun; 52():151722. PubMed ID: 33621744
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3α.
Wang N; Zhu Y; Xie M; Wang L; Jin F; Li Y; Yuan Q; De W
Cell Physiol Biochem; 2018; 45(5):2031-2043. PubMed ID: 29529600
[TBL] [Abstract][Full Text] [Related]
13. Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.
Han LL; Hou L; Zhou MJ; Ma ZL; Lin DL; Wu L; Ge YL
J Biomed Sci; 2013 Jul; 20(1):52. PubMed ID: 23899187
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.
Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O
Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the interaction between the cohesin subunits Rad21 and SA1/2.
Zhang N; Jiang Y; Mao Q; Demeler B; Tao YJ; Pati D
PLoS One; 2013; 8(7):e69458. PubMed ID: 23874961
[TBL] [Abstract][Full Text] [Related]
16. DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex.
Nanavaty V; Abrash EW; Hong C; Park S; Fink EE; Li Z; Sweet TJ; Bhasin JM; Singuri S; Lee BH; Hwang TH; Ting AH
Mol Cell; 2020 May; 78(4):752-764.e6. PubMed ID: 32333838
[TBL] [Abstract][Full Text] [Related]
17. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
18. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients.
Wei J; Han B; Mao XY; Wei MJ; Yao F; Jin F
Tumour Biol; 2012 Apr; 33(2):413-20. PubMed ID: 21922275
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.
Wang Y; Lu R; Chen P; Cui R; Ji M; Zhang X; Hou P; Qu Y
BMC Cancer; 2022 Sep; 22(1):951. PubMed ID: 36064388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
